跳至主要内容
临床试验/NCT01666405
NCT01666405终止1 期

A Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

Uroplasty, Inc12 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
1 期
状态
终止
入组人数
30
试验地点
12
主要终点
Effectiveness

研究概览

简要总结

The purpose of this study is to determine the effectiveness of percutaneous tibial nerve stimulation (PTNS) therapy with the Urgent® PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA) for the treatment of fecal incontinence (FI).

详细描述

Pilot Study

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient history of chronic FI of more than staining for at least 6 months; staining defined as less than the size of a 25¢ piece (quarter)
  • Patient reported and/or failed ≥ 2 conservative therapies (e.g., diet/fiber modification, anti-diarrheal medication, pelvic floor muscle training, biofeedback, medical management, etc.)

排除标准

  • Pregnancy or intention to become pregnant during the course of the study
  • Implanted electro-medical device (i.e., pacemaker, defibrillator, deep brain stimulator, etc.)
  • Clinically significant neurological diseases or nerve damage impacting tibial nerve or pelvic floor function
  • Prone to excessive bleeding or bleeding diathesis

结局指标

主要结局

Effectiveness

时间窗: 18 weeks

To assess the effectiveness of PTNS by measuring the proportion of patients with ≥50% decrease in the number of fecal incontinence episodes per week based on the results of the 14-day bowel diary at 18 weeks compared to baseline

Safety

时间窗: 18 weeks

To characterize adverse events experienced throughout the study

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验